Content about Renal dialysis

September 4, 2012

Impax settles with Genzyme over kidney dialysis drugs

Generic drug maker Impax Labs has settled with a subsidiary of Sanofi regarding generic versions of two drugs for dialysis patients, Impax said Tuesday.

June 28, 2012

Botanical Labs launches gluten-free protein liquid supplement

Botanical Labs on Wednesday launched its certified gluten-free Protein Complete liquid dietary supplement that is fortified with 10 g of protein per 1-oz. serving.

January 12, 2012

Active Health Foods rolls out Active X bar for dialysis patients

Active Health Foods has introduced an energy bar designed for dialysis patients.

February 8, 2011

Vascugel granted fast-track designation by FDA

The Food and Drug Administration has given expedited review to a drug for preventing hemodialysis failure in patients with end-stage kidney disease.

December 1, 2010

Keryx: Zerenex reduces phosphate levels in patients on kidney dialysis

Drug maker Keryx Biopharmaceuticals got promising results from a late-stage clinical trial of a drug for treating elevated phosphate levels, also known as hyperphosphatemia, in patients on kidney dialysis, the company said Tuesday.

September 28, 2010

Keryx commences phase-3 trial for Zerenex

Keryx has begun its phase-3 clinicial trial of a drug designed to treat elevated serum...

July 12, 2010

Watson seeks FDA approval for generic Renvela, confirms patent challenge

Generic drug maker Watson Pharmaceuticals hopes to be the first to market a version of...

July 5, 2010

Impax challenges Renvela patent

Generic drug maker Impax Labs is challenging the patent on a drug used to treat...